Clarity Pharmaceuticals Ltd.ASX: CU6

Positive guidance from the US FDA on Cu-64 SARTATE Phase III

· Issued by Clarity Pharmaceuticals Ltd.

Filed with ASX · · 3 pages · English

Clarity Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases